Wohngeld-Reform: Über 400.000 Haushalte könnten Ansprüche verlieren
Fluor Aktie: Dreifacher Auftragsschub
NN stock: Company raises 2026 outlook after strong Q3
Inhibrx Biosciences stock faces a busy clinical-data calendar
KLA-Tencor Aktie: S&P hebt Rating auf A
Lennox stock faces lower outlook after third-quarter margin pressure
Rolls-Royce's Technical Wins Face a Customer's Verdict
Rheinmetall's Strong Quarter Meets a Softer Year as Arminius Slips
Nvidia's Cloud Rulebook Is Being Rewritten in Real Time — and the 17 November Call Won't Settle It
Iveda stock heads toward November 10 GX11 flight demonstration
El Condor stock: Q2 profit returns as revenue falls 26%
Mundial stock: Q2 revenue rises as loss narrows
OneSpan stock: Q3 growth backs higher 2026 outlook
Hyliion stock: Q3 results set for November 10
Kniebeugen bei Arthrose: Tiefe Varianten verdreifachen den Gelenkdruck
ParkOhio stock draws focus as company raises 2026 outlook
Glaukos stock gets a stronger 2026 outlook after Q3 growth
Pure Storage stock trades at Lang & Schwarz before fiscal results
Full House Resorts stock faces debt clarity test before results
Fidelity National Financial stock faces pressure from falling premiums
Android 13 und älter: 43,6 Prozent der Geräte erhalten den Patch nicht
Multiplan stock: R$1 billion mall sales cut leverage
Outlook-Suche: Microsoft senkt die langsamsten Suchzeiten auf 1,3 Sekunden
Estée Lauder stock gains momentum as outlook rises after Q1 recovery
Remitly Global Aktie: Gewinnsprung mit RĂĽckenwind
Intrusion stock faces Nasdaq hurdle after $4 million debt swap
ProPhase Labs stock: Venkatesan reports 5.48% stake
MSI Cubi NUC WCG: Gehäuse lässt sich in zwei Schritten werkzeuglos öffnen
Columbia Sportswear Aktie: FĂĽhrungsriege verkauft
Applied Digital Aktie: Texas-Wahl verunsichert Rechenzentrumsausbau
Immunome stock: IM-1021 shows 53% lymphoma response rate
nCino stock approaches December earnings after AI suite launch
LVMH Climbs 4.5% as Sector Tailwind Outruns a Downgrade and a French Probe
Hensoldt's Warehouse Headache Meets a Valuation Wall Ahead of Two November Dates
Lenzing Investors Get Their Answer Day After a 5.4% Run-Up